Pinnacle Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-769
Closed -$48.3K 233
2022
Q1
$48.3K Buy
+769
New +$48.3K 0.02% 194